Nevro Receives 4 Patents for Chronic Pain Device

Nevro in Menlo Park, Calif., a medical device company, has announced the issuance of four additional key patents related to the company’s Senza(R) system and High-Frequency Spinal Cord Stimulation therapy.

Advertisement

The Senza system, which aims at providing relief from chronic pain, is available in Europe and Australia. It is presently undergoing investigation in a clinical trial in the United States.

More Articles on Pain Management:

Dr. Ritu Verma Joins American Spine
Georgia Rep. Tom Weldon to Sponsor Pain Clinic Regulation Bill
Prospira PainCare to Deploy Athenahealth’s Cloud-Based & EHR Services

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.